Histologic Evolution of Lung Adenocarcinomas with Acquired Resistance to Epidermal Growth Factor Receptor (EGFR) Inhibitors

被引：0
|
作者：
Cai, G. [1 ]
Gettinger, S. N. [1 ]
Walther, Z. [1 ]
Wurtz, A. K. [1 ]
Pirazzoli, V. [1 ]
Bao, Y. [1 ]
Homer, R. J. [1 ]
Politi, K. [1 ]
机构：
[1] Yale Univ, Sch Med, New Haven, CT USA
来源：
MODERN PATHOLOGY | 2014年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1947
引用
收藏
页码：474A / 474A
页数：1
相关论文
共 50 条
  • [1] Histologic Evolution of Lung Adenocarcinomas with Acquired Resistance to Epidermal Growth Factor Receptor (EGFR) Inhibitors
    Cai, G.
    Gettinger, S. N.
    Walther, Z.
    Wurtz, A. K.
    Pirazzoli, V.
    Bao, Y.
    Homer, R. J.
    Politi, K.
    LABORATORY INVESTIGATION, 2014, 94 : 474A - 474A
  • [2] Morphologic features of lung adenocarcinomas in relation to responsiveness to epidermal growth factor receptor (EGFR) inhibitors and EGFR mutational status
    Zakowski, MF
    Hussian, S
    Pao, W
    Miller, VA
    Kris, MG
    MODERN PATHOLOGY, 2005, 18 : 321A - 321A
  • [3] Morphologic features of lung adenocarcinomas in relation to responsiveness to epidermal growth factor receptor (EGFR) inhibitors and EGFR mutational status
    Zakowski, MF
    Hussain, S
    Pao, W
    Miller, VA
    Kris, MG
    LABORATORY INVESTIGATION, 2005, 85 : 321A - 321A
  • [4] HISTOLOGIC AND GENOTYPIC EVOLUTION IN LUNG CANCER HARBORING MUTATIONS IN THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR): A CLINICAL CASE
    Vavala, Tiziana
    Righi, Luisella
    Vatrano, Simona
    Cappia, Susanna
    Gobbini, Elisa
    Rapetti, Simonetta G.
    Novello, Silvia
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1301 - S1302
  • [5] Complex epidermal growth factor receptor (EGFR) mutations and responses to tyrosine kinase inhibitors (TKIs) in advanced lung adenocarcinomas
    Zhang, B.
    Wang, S.
    Qian, J.
    Yang, W.
    Qian, F.
    Lu, J.
    Zhang, Y.
    Qiao, R.
    Han, B.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S82 - S82
  • [6] Epidermal Growth Factor Receptor Mutation in Lung Adenocarcinomas: Relationship with CT Characteristics and Histologic Subtypes
    Lee, Hyun-Ju
    Kim, Young Tae
    Kang, Chang Hyun
    Zhao, Binsheng
    Tan, Yongqiang
    Schwartz, Lawrence H.
    Persigehl, Thorsten
    Jeon, Yoon Kyung
    Chung, Doo Hyun
    RADIOLOGY, 2013, 268 (01) : 254 - 264
  • [7] Correlation analysis on epidermal growth factor receptor (EGFR) mutations and clinicopathological characteristics in lung adenocarcinomas
    Wang, Haitao
    Ji, Changhua
    Zhou, Chengjun
    Li, Hui
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [8] Cytomorphologic and Molecular Evolution of EGFR-Mutated Lung Adenocarcinomas with Acquired Resistance to Tyrosine Kinase Inhibitors
    Doxtader, Erika E.
    Brainard, Jennifer A.
    Sturgis, Charles D.
    Velcheti, Vamsidar
    Zhang, Yaxia
    LABORATORY INVESTIGATION, 2017, 97 : 93A - 93A
  • [9] Epidermal growth factor receptor (EGFR)-activating mutations (mut) and response to gefitinib in lung adenocarcinomas
    Moran, T
    de Castellanos, D
    Gomez, C
    Valero, P
    Alberola, V
    Gonzalez-Larriba, J
    Massuti, B
    Maestu, I
    Izquierdo, A
    Queralt, C
    LUNG CANCER, 2005, 49 : S110 - S110
  • [10] Cytomorphologic and Molecular Evolution of EGFR-Mutated Lung Adenocarcinomas with Acquired Resistance to Tyrosine Kinase Inhibitors
    Doxtader, Erika E.
    Brainard, Jennifer A.
    Sturgis, Charles D.
    Velcheti, Vamsidar
    Zhang, Yaxia
    MODERN PATHOLOGY, 2017, 30 : 93A - 93A
12345